Thomas Bülter

3.4k citations
22 papers · 2.7k indexed · 1 hit paper · h-index 16

Impact in

Papers in

Thomas Bülter

22 papers receiving 2.6k citations

Hit Papers

A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity 2001 · 1.1k citations
1.1k20012026200920172505007501000

Peers

Thomas Bülter
Comparison fields: 5 of 111
  • Biological Psychiatry 99
  • Biotechnology 341
  • Physiology 813
  • Pharmacology 476
  • Neurology 228
Replace Jean‐Pierre Monti with:
Jean‐Pierre Monti France
Patrick R. Verhoest United States
Ae Nim Pae South Korea
Kazuma Murakami Japan
Rui‐tian Liu China
Ki Duk Park South Korea
Robert E. Zipkin United States
Young‐Ger Suh South Korea
Harrie J. M. Gijsen Belgium
Yasir Hasan Siddique India
Thomas Bülter relative to Jean‐Pierre Monti France Jean‐Pierre Monti's profile →
Citations per field
00.5×3.7×
Jean‐Pierre Monti · 1×
Citations per year

Countries citing papers authored by Thomas Bülter

Since Specialization
Citations

This map shows the geographic impact of Thomas Bülter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Bülter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Bülter more than expected).

Fields of papers citing papers by Thomas Bülter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Bülter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Bülter. The network helps show where Thomas Bülter may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Thomas Bülter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas Bülter Line = papers co-authored together Thomas Bülter links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 2015147
2 201527
3 20083
4 200789
5 200714
6 200547
7 2005290
8 2004123
9 200319
10 200314
11 20039
12 20037
13 20036
14 200291
15 200261
16 2001233
17 200122
18
A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
Hit paper breakdown →
20011103
19 200016
20 1999108

About Thomas Bülter

Thomas Bülter is a scholar working on Biochemistry, Biotechnology, Molecular Biology, Cell Biology and Plant Science, having authored 22 papers that have together received 2.7k indexed citations. Recurring topics across this work include Enzyme-mediated dye degradation (6 papers), Microbial Metabolic Engineering and Bioproduction (5 papers), Amino Acid Enzymes and Metabolism (4 papers), Enzyme Catalysis and Immobilization (4 papers), Microbial Metabolism and Applications (4 papers), Gene Regulatory Network Analysis (3 papers), CRISPR and Genetic Engineering (3 papers) and Bacterial Genetics and Biotechnology (3 papers). The work is most often cited by research in Biological Psychiatry (99 citations), Biotechnology (341 citations), Physiology (813 citations), Pharmacology (476 citations) and Neurology (228 citations). Thomas Bülter has collaborated with scholars based in United States, Germany and Austria. Frequent co-authors include Frances H. Arnold, Miguel Alcalde, James C. Liao, Michael P. Murphy, Sarah A. Sagi, Claus U. Pietrzik, Sascha Weggen, Kirk A. Findlay, Todd E. Golde and Jason L. Eriksen. Their work appears in journals such as SLAS DISCOVERY, Nature, Applied and Environmental Microbiology, ChemBioChem and Biotechnology and Bioengineering.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026